Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1972 Nov 30;136(6):1329–1343. doi: 10.1084/jem.136.6.1329

EVIDENCE THAT THE BONE RESORPTION-STIMULATING FACTOR PRODUCED BY MOUSE FIBROSARCOMA CELLS IS PROSTAGLANDIN E2

A NEW MODEL FOR THE HYPERCALCEMIA OF CANCER

Armen H Tashjian Jr 1, Edward F Voelkel 1, Lawrence Levine 1, Paul Goldhaber 1
PMCID: PMC2139337  PMID: 4345106

Abstract

A transplantable mouse fibrosarcoma, HSDM1, produces a potent bone resorption-stimulating factor. The factor can be extracted from the tumor tissue and harvested from the medium of clonal strains of HSDM1 tumor cells growing in monolayer culture. It has several chemical and biological properties of a prostaglandin. Using radioimmunoassay techniques, we have shown that HSDM1 cells synthesize and secrete large quantities of prostaglandin E2 (PGE2). The specific bone resorption-stimulating activity of the HSDM1 factor extracted from the tumor is high and approximately equal to that of PGE2 as measured in a bone tissue culture system in vitro. Indomethacin, a potent inhibitor of PGE2 synthesis in HSDM1 cells, also inhibits production by the cells of the bone resorption-stimulating factor, and has no detectable nonspecific effects on the bone culture assay system. Mice bearing the HSDM1 tumor have higher levels of both calcium and PGE2 in serum than control mice. We conclude that PGE2 is the bone resorption-stimulating factor produced by HSDM1 tumor cells, and that secretion of PGE2 by the tumor in vivo accounts for the relative hypercalcemia observed in tumor-bearing animals. The HSDM1 tumor cell system constitutes a new model for studying the pathogenesis of hypercalcemia associated with certain malignant tumors.

Full Text

The Full Text of this article is available as a PDF (839.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOWER B. F., GORDAN G. S. HORMONAL EFFECTS OF NONENDOCRINE TUMORS. Annu Rev Med. 1965;16:83–118. doi: 10.1146/annurev.me.16.020165.000503. [DOI] [PubMed] [Google Scholar]
  2. COPP D. H. Simple and precise micromethod for EDTA titration of calcium. J Lab Clin Med. 1963 Jun;61:1029–1037. [PubMed] [Google Scholar]
  3. Gutierrez Cernosek R. M., Morrill L. M., Levine L. Prostaglandin F2alpha levels in peripheral sera of man. Prostaglandins. 1972 Jan;1(1):71–80. doi: 10.1016/0090-6980(72)90066-4. [DOI] [PubMed] [Google Scholar]
  4. HAM R. G. An improved nutrient solution for diploid Chinese hamster and human cell lines. Exp Cell Res. 1963 Feb;29:515–526. doi: 10.1016/s0014-4827(63)80014-2. [DOI] [PubMed] [Google Scholar]
  5. Klein D. C., Raisz L. G. Prostaglandins: stimulation of bone resorption in tissue culture. Endocrinology. 1970 Jun;86(6):1436–1440. doi: 10.1210/endo-86-6-1436. [DOI] [PubMed] [Google Scholar]
  6. Levine L., Gjtierrez Cernosek R. M., Van Vunakis H. Specificities of prostaglandins B 1 , F 1 , and F 2 antigen-antibody reactions. J Biol Chem. 1971 Nov 25;246(22):6782–6785. [PubMed] [Google Scholar]
  7. Levine L., Hinkle P. M., Voelkel E. F., Tashjian A. H., Jr Prostaglandin production by mouse fibrosarcoma cells in culture: inhibition by indomethacin and aspirin. Biochem Biophys Res Commun. 1972 May 26;47(4):888–896. doi: 10.1016/0006-291x(72)90576-1. [DOI] [PubMed] [Google Scholar]
  8. Munson P. L., Tashjian A. H., Jr, Levine L. Evidence for parathyroid hormone in nonparathyroid tumors associated with hypercalcemia. Cancer Res. 1965 Aug;25(7):1062–1067. [PubMed] [Google Scholar]
  9. Sherwood L. M., O'Riordan J. L., Aurbach G. D., Potts J. T., Jr Production of parathyroid hormone by nonparthyroid tumors. J Clin Endocrinol Metab. 1967 Jan;27(1):140–146. doi: 10.1210/jcem-27-1-140. [DOI] [PubMed] [Google Scholar]
  10. Sykes J. A., Moddox I. S. Prostaglandin production by experimental tumours and effects of anti-inflammatory compounds. Nat New Biol. 1972 May 10;237(71):59–61. doi: 10.1038/newbio237059a0. [DOI] [PubMed] [Google Scholar]
  11. TASHJIAN A. H., Jr, LEVINE L., MUNSON P. L. IMMUNOCHEMICAL IDENTIFICATION OF PARATHYROID HORMONE IN NON-PARATHYROID NEOPLASMS ASSOCIATED WITH HYPERCALCEMIA. J Exp Med. 1964 Mar 1;119:467–484. doi: 10.1084/jem.119.3.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Tashjian A. H., Jr, Yasumura Y., Levine L., Sato G. H., Parker M. L. Establishment of clonal strains of rat pituitary tumor cells that secrete growth hormone. Endocrinology. 1968 Feb;82(2):342–352. doi: 10.1210/endo-82-2-342. [DOI] [PubMed] [Google Scholar]
  13. Williams E. D., Karim S. M., Sandler M. Prostaglandin secretion by medullary carcinoma of the thyroid. A possible cause of the associated idarrhoea. Lancet. 1968 Jan 6;1(7532):22–23. doi: 10.1016/s0140-6736(68)90010-x. [DOI] [PubMed] [Google Scholar]
  14. Yasamura Y., Tashjian A. H., Jr, Sato G. H. Establishment of four functional, clonal strains of animal cells in culture. Science. 1966 Dec 2;154(3753):1186–1189. doi: 10.1126/science.154.3753.1186. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES